International Cancer Research Conference
March 24-26, 2025 | Singapore
Clinical Research & Clinical Trials of cancer
Clinical research is a type of medical and health study that aims to provide knowledge that will aid in the understanding of human disease, the prevention and treatment of illness, and the promotion of health. Clinical research encompasses a broad array of investigations that involve patient interaction, diagnostic clinical materials or data, or demographics.
Clinical trials are human-centered research studies. Doctors use clinical trials to discover novel approaches to improve disease treatments and patient quality of life. People are living longer lives today as a result of successful cancer treatments developed through clinical trials in the past. Doctors use clinical trials to see if new medicines are safe and effective, and if they function better than existing treatments. Clinical trials also aid in the discovery of new cancer prevention and detection methods.
- Treat cancer
- Find and diagnose cancer
- Prevent cancer
- Manage symptoms of cancer
- Side effects from cancer treatment
- Cancer therapy
- Pharmaceutical advancements
- Drug delivery
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
Seattle Children’s Hospital, United States
Michael Thompson
University of Toronto, Canada
Kaushala Prasad Mishra
Asian Association for Radiation Research (AARR), India
Mariola Wioletta Borowska
Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Andrea González Báez
Autonomous University of Nuevo Leon, Mexico
Qian Zhang
The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, ChinaSubmit your abstract Today
Title :
Patricia Tai, Saskatchewan Cancer Agency, Canada
Title :
Atif A Ahmed, Seattle Children’s Hospital, United States
Title :
Marika Crohns, Sanofi, Germany
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada